<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-12-15" modified="2017-10-25" version="168">
<accession>Q16696</accession>
<accession>Q53YR8</accession>
<accession>Q6R569</accession>
<accession>Q6R570</accession>
<accession>Q9H2X2</accession>
<name>CP2AD_HUMAN</name>
<protein>
<recommendedName>
<fullName>Cytochrome P450 2A13</fullName>
<ecNumber>1.14.14.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CYPIIA13</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">CYP2A13</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="Am. J. Hum. Genet." volume="57" first="651" last="660">
<title>A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.</title>
<authorList>
<person name="Fernandez-Salguero P."/>
<person name="Hoffman S.M."/>
<person name="Cholerton S."/>
<person name="Mohrenweiser H."/>
<person name="Raunio H."/>
<person name="Rautio A."/>
<person name="Pelkonen O."/>
<person name="Huang J.D."/>
<person name="Evans W.E."/>
<person name="Idle J.R."/>
</authorList>
<dbReference type="PubMed" id="7668294"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Cancer Res." volume="60" first="5074" last="5079">
<title>Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.</title>
<authorList>
<person name="Su T."/>
<person name="Bao Z."/>
<person name="Zhang Q.Y."/>
<person name="Smith T.J."/>
<person name="Hong J.Y."/>
<person name="Ding X."/>
</authorList>
<dbReference type="PubMed" id="11016631"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>CHARACTERIZATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="317" first="662" last="669">
<title>Genetic polymorphism of the human cytochrome CYP2A13 in a French population: implication in lung cancer susceptibility.</title>
<authorList>
<person name="Cauffiez C."/>
<person name="Lo-Guidice J.-M."/>
<person name="Quaranta S."/>
<person name="Allorge D."/>
<person name="Chevalier D."/>
<person name="Cenee S."/>
<person name="Hamdan R."/>
<person name="Lhermitte M."/>
<person name="Lafitte J.-J."/>
<person name="Libersa C."/>
<person name="Colombel J.-F."/>
<person name="Stuecker I."/>
<person name="Broly F."/>
</authorList>
<dbReference type="PubMed" id="15063809"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.03.092"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANTS GLU-158 AND LEU-323</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2008" name="Drug Metab. Dispos." volume="36" first="2582" last="2590">
<title>Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes.</title>
<authorList>
<person name="DeVore N.M."/>
<person name="Smith B.D."/>
<person name="Urban M.J."/>
<person name="Scott E.E."/>
</authorList>
<dbReference type="PubMed" id="18779312"/>
<dbReference type="DOI" id="10.1124/dmd.108.023770"/>
</citation>
<scope>FUNCTION</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>MUTAGENESIS OF LEU-110; ALA-117; SER-208; ALA-213; PHE-300; ALA-301; MET-365; LEU-366; GLY-369 AND HIS-372</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="Arch. Biochem. Biophys." volume="464" first="197" last="206">
<title>Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants.</title>
<authorList>
<person name="Sansen S."/>
<person name="Hsu M.H."/>
<person name="Stout C.D."/>
<person name="Johnson E.F."/>
</authorList>
<dbReference type="PubMed" id="17540336"/>
<dbReference type="DOI" id="10.1016/j.abb.2007.04.028"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 29-494 IN COMPLEX WITH HEME</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="17306" last="17313">
<title>Structure of the human lung cytochrome P450 2A13.</title>
<authorList>
<person name="Smith B.D."/>
<person name="Sanders J.L."/>
<person name="Porubsky P.R."/>
<person name="Lushington G.H."/>
<person name="Stout C.D."/>
<person name="Scott E.E."/>
</authorList>
<dbReference type="PubMed" id="17428784"/>
<dbReference type="DOI" id="10.1074/jbc.M702361200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 31-494 IN COMPLEX WITH SUBSTRATE ANALOG AND HEME</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="J. Pharmacol. Exp. Ther." volume="302" first="416" last="423">
<title>Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant.</title>
<authorList>
<person name="Zhang X."/>
<person name="Su T."/>
<person name="Zhang Q.Y."/>
<person name="Gu J."/>
<person name="Caggana M."/>
<person name="Li H."/>
<person name="Ding X."/>
</authorList>
<dbReference type="PubMed" id="12130698"/>
<dbReference type="DOI" id="10.1124/jpet.302.2.416"/>
</citation>
<scope>VARIANT CYS-257</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Drug Metab. Pharmacokinet." volume="18" first="86" last="90">
<title>Eighteen novel polymorphisms of the CYP2A13 gene in Japanese.</title>
<authorList>
<person name="Fujieda M."/>
<person name="Yamazaki H."/>
<person name="Kiyotani K."/>
<person name="Muroi A."/>
<person name="Kunitoh H."/>
<person name="Dosaka-Akita H."/>
<person name="Sawamura Y."/>
<person name="Kamataki T."/>
</authorList>
<dbReference type="PubMed" id="15618722"/>
<dbReference type="DOI" id="10.2133/dmpk.18.86"/>
</citation>
<scope>VARIANTS GLN-25; GLN-101; THR-134 INS; GLU-158; TYR-453 AND CYS-494</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Hum. Genet." volume="48" first="249" last="270">
<title>Catalog of 680 variations among eight cytochrome p450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population.</title>
<authorList>
<person name="Saito S."/>
<person name="Iida A."/>
<person name="Sekine A."/>
<person name="Kawauchi S."/>
<person name="Higuchi S."/>
<person name="Ogawa C."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="12721789"/>
<dbReference type="DOI" id="10.1007/s10038-003-0021-7"/>
</citation>
<scope>VARIANTS GLN-25 AND CYS-257</scope>
</reference>
<comment type="function">
<text evidence="11">Exhibits a coumarin 7-hydroxylase activity. Active in the metabolic activation of hexamethylphosphoramide, N,N-dimethylaniline, 2'-methoxyacetophenone, N-nitrosomethylphenylamine, and the tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Possesses phenacetin O-deethylation activity.</text>
</comment>
<comment type="catalytic activity">
<text>RH + [reduced NADPH--hemoprotein reductase] + O(2) = ROH + [oxidized NADPH--hemoprotein reductase] + H(2)O.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>heme</name>
<dbReference type="ChEBI" id="CHEBI:30413"/>
</cofactor>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="11">10.7 uM for phenacetin</KM>
</kinetics>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Endoplasmic reticulum membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Microsome membrane</location>
<topology>Peripheral membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="6">Expressed in liver and a number of extrahepatic tissues, including nasal mucosa, lung, trachea, brain, mammary gland, prostate, testis, and uterus, but not in heart, kidney, bone marrow, colon, small intestine, spleen, stomach, thymus, or skeletal muscle.</text>
</comment>
<comment type="polymorphism">
<text>The frequencies of the Cys-257 allele in white, black, Hispanic, and Asian individuals are 1.9%, 14.4%, 5.8%, and 7.7%, respectively. The Cys-257 variant is 37 to 56% less active than the wild-type Arg-257 protein toward all substrates tested.</text>
</comment>
<comment type="similarity">
<text evidence="12">Belongs to the cytochrome P450 family.</text>
</comment>
<comment type="online information" name="Cytochrome P450 Allele Nomenclature Committee">
<link uri="http://www.cypalleles.ki.se/cyp2a13.htm"/>
<text>CYP2A13 alleles</text>
</comment>
<dbReference type="EC" id="1.14.14.1"/>
<dbReference type="EMBL" id="U22028">
<property type="protein sequence ID" value="AAB40519.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF209774">
<property type="protein sequence ID" value="AAG35775.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY513604">
<property type="protein sequence ID" value="AAR90935.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY513605">
<property type="protein sequence ID" value="AAR90936.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY513606">
<property type="protein sequence ID" value="AAR90937.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY513608">
<property type="protein sequence ID" value="AAR90939.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY513609">
<property type="protein sequence ID" value="AAR90940.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12571.1"/>
<dbReference type="PIR" id="I38966">
<property type="entry name" value="I38966"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000757.2">
<property type="nucleotide sequence ID" value="NM_000766.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.567252"/>
<dbReference type="PDB" id="2P85">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B/C/D/E/F=26-494"/>
</dbReference>
<dbReference type="PDB" id="2PG5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B/C/D=31-494"/>
</dbReference>
<dbReference type="PDB" id="2PG6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.53"/>
<property type="chains" value="A/B/C/D=31-494"/>
</dbReference>
<dbReference type="PDB" id="2PG7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D=31-494"/>
</dbReference>
<dbReference type="PDB" id="3T3S">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B/C/D/E/F/G/H=31-494"/>
</dbReference>
<dbReference type="PDB" id="4EJG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D/E/F/G/H=31-494"/>
</dbReference>
<dbReference type="PDB" id="4EJH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B/C/D/E/F/G/H=31-494"/>
</dbReference>
<dbReference type="PDB" id="4EJI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=31-494"/>
</dbReference>
<dbReference type="PDBsum" id="2P85"/>
<dbReference type="PDBsum" id="2PG5"/>
<dbReference type="PDBsum" id="2PG6"/>
<dbReference type="PDBsum" id="2PG7"/>
<dbReference type="PDBsum" id="3T3S"/>
<dbReference type="PDBsum" id="4EJG"/>
<dbReference type="PDBsum" id="4EJH"/>
<dbReference type="PDBsum" id="4EJI"/>
<dbReference type="ProteinModelPortal" id="Q16696"/>
<dbReference type="SMR" id="Q16696"/>
<dbReference type="BioGrid" id="107931">
<property type="interactions" value="1"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000332679"/>
<dbReference type="BindingDB" id="Q16696"/>
<dbReference type="ChEMBL" id="CHEMBL3542436"/>
<dbReference type="DrugBank" id="DB00553">
<property type="generic name" value="Methoxsalen"/>
</dbReference>
<dbReference type="DrugBank" id="DB00184">
<property type="generic name" value="Nicotine"/>
</dbReference>
<dbReference type="DrugBank" id="DB03783">
<property type="generic name" value="Phenacetin"/>
</dbReference>
<dbReference type="DrugBank" id="DB00624">
<property type="generic name" value="Testosterone"/>
</dbReference>
<dbReference type="iPTMnet" id="Q16696"/>
<dbReference type="PhosphoSitePlus" id="Q16696"/>
<dbReference type="BioMuta" id="CYP2A13"/>
<dbReference type="DMDM" id="77416854"/>
<dbReference type="EPD" id="Q16696"/>
<dbReference type="PaxDb" id="Q16696"/>
<dbReference type="PeptideAtlas" id="Q16696"/>
<dbReference type="PRIDE" id="Q16696"/>
<dbReference type="DNASU" id="1553"/>
<dbReference type="Ensembl" id="ENST00000330436">
<property type="protein sequence ID" value="ENSP00000332679"/>
<property type="gene ID" value="ENSG00000197838"/>
</dbReference>
<dbReference type="GeneID" id="1553"/>
<dbReference type="KEGG" id="hsa:1553"/>
<dbReference type="UCSC" id="uc002opt.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1553"/>
<dbReference type="DisGeNET" id="1553"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000197838.4"/>
<dbReference type="GeneCards" id="CYP2A13"/>
<dbReference type="HGNC" id="HGNC:2608">
<property type="gene designation" value="CYP2A13"/>
</dbReference>
<dbReference type="HPA" id="HPA046713"/>
<dbReference type="HPA" id="HPA047262"/>
<dbReference type="MIM" id="608055">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q16696"/>
<dbReference type="OpenTargets" id="ENSG00000197838"/>
<dbReference type="PharmGKB" id="PA27101"/>
<dbReference type="eggNOG" id="KOG0156">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG2124">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00880000137861"/>
<dbReference type="HOGENOM" id="HOG000036992"/>
<dbReference type="HOVERGEN" id="HBG015789"/>
<dbReference type="InParanoid" id="Q16696"/>
<dbReference type="KO" id="K17685"/>
<dbReference type="OMA" id="WSEIMET"/>
<dbReference type="OrthoDB" id="EOG091G0BT8"/>
<dbReference type="PhylomeDB" id="Q16696"/>
<dbReference type="TreeFam" id="TF352043"/>
<dbReference type="Reactome" id="R-HSA-211935">
<property type="pathway name" value="Fatty acids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211981">
<property type="pathway name" value="Xenobiotics"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211999">
<property type="pathway name" value="CYP2E1 reactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5423646">
<property type="pathway name" value="Aflatoxin activation and detoxification"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q16696"/>
<dbReference type="EvolutionaryTrace" id="Q16696"/>
<dbReference type="GeneWiki" id="CYP2A13"/>
<dbReference type="GenomeRNAi" id="1553"/>
<dbReference type="PRO" id="PR:Q16696"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000197838"/>
<dbReference type="CleanEx" id="HS_CYP2A13"/>
<dbReference type="Genevisible" id="Q16696">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031090">
<property type="term" value="C:organelle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0008392">
<property type="term" value="F:arachidonic acid epoxygenase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070330">
<property type="term" value="F:aromatase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0008389">
<property type="term" value="F:coumarin 7-hydroxylase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0020037">
<property type="term" value="F:heme binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005506">
<property type="term" value="F:iron ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0019825">
<property type="term" value="F:oxygen binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008395">
<property type="term" value="F:steroid hydroxylase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0009804">
<property type="term" value="P:coumarin metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019373">
<property type="term" value="P:epoxygenase P450 pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006805">
<property type="term" value="P:xenobiotic metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.630.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001128">
<property type="entry name" value="Cyt_P450"/>
</dbReference>
<dbReference type="InterPro" id="IPR017972">
<property type="entry name" value="Cyt_P450_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002401">
<property type="entry name" value="Cyt_P450_E_grp-I"/>
</dbReference>
<dbReference type="InterPro" id="IPR008067">
<property type="entry name" value="Cyt_P450_E_grp-I_CYP2A-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036396">
<property type="entry name" value="Cyt_P450_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF00067">
<property type="entry name" value="p450"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00463">
<property type="entry name" value="EP450I"/>
</dbReference>
<dbReference type="PRINTS" id="PR01684">
<property type="entry name" value="EP450ICYP2A"/>
</dbReference>
<dbReference type="PRINTS" id="PR00385">
<property type="entry name" value="P450"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48264">
<property type="entry name" value="SSF48264"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00086">
<property type="entry name" value="CYTOCHROME_P450"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0349">Heme</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0492">Microsome</keyword>
<keyword id="KW-0503">Monooxygenase</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<feature type="chain" description="Cytochrome P450 2A13" id="PRO_0000051676">
<location>
<begin position="1"/>
<end position="494"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron (heme axial ligand)">
<location>
<position position="439"/>
</location>
</feature>
<feature type="binding site" description="Substrate">
<location>
<position position="297"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="131"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="5">
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A13*2; dbSNP:rs8192784." id="VAR_018334" evidence="8 10">
<original>R</original>
<variation>Q</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A13*4; dbSNP:rs148044792." id="VAR_018335" evidence="10">
<original>R</original>
<variation>Q</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A13*3." id="VAR_018336" evidence="10">
<original>T</original>
<variation>TT</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A13*3 and allele CYP2A13*8; dbSNP:rs112337232." id="VAR_018337" evidence="9 10">
<original>D</original>
<variation>E</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A13*2; dbSNP:rs8192789." id="VAR_013835" evidence="7 8">
<original>R</original>
<variation>C</variation>
<location>
<position position="257"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A13*9." id="VAR_018356" evidence="9">
<original>V</original>
<variation>L</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A13*5; dbSNP:rs72547590." id="VAR_018338" evidence="10">
<original>F</original>
<variation>Y</variation>
<location>
<position position="453"/>
</location>
</feature>
<feature type="sequence variant" description="In allele CYP2A13*6; dbSNP:rs138870349." id="VAR_018339" evidence="10">
<original>R</original>
<variation>C</variation>
<location>
<position position="494"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phenacetin O-deethylation activity 8 fold." evidence="11">
<original>L</original>
<variation>V</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases phenacetin O-deethylation activity 5 fold." evidence="11">
<original>A</original>
<variation>V</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phenacetin O-deethylation activity 10 fold." evidence="11">
<original>S</original>
<variation>I</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phenacetin O-deethylation activity 2 fold." evidence="11">
<original>A</original>
<variation>S</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phenacetin O-deethylation activity 40 fold." evidence="11">
<original>F</original>
<variation>I</variation>
<location>
<position position="300"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phenacetin O-deethylation activity 20 fold." evidence="11">
<original>A</original>
<variation>G</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phenacetin O-deethylation activity 7 fold." evidence="11">
<original>M</original>
<variation>V</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases phenacetin O-deethylation activity 3 fold." evidence="11">
<original>L</original>
<variation>I</variation>
<location>
<position position="366"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phenacetin O-deethylation activity 9 fold." evidence="11">
<original>G</original>
<variation>S</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases phenacetin O-deethylation activity 3 fold." evidence="11">
<original>H</original>
<variation>R</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB40519." ref="1" evidence="12">
<original>S</original>
<variation>R</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB40519." ref="1" evidence="12">
<original>A</original>
<variation>G</variation>
<location>
<position position="213"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB40519." ref="1" evidence="12">
<original>V</original>
<variation>E</variation>
<location>
<position position="398"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB40519." ref="1" evidence="12">
<original>RDFN</original>
<variation>QDCS</variation>
<location>
<begin position="409"/>
<end position="412"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAB40519." ref="1" evidence="12">
<original>K</original>
<variation>E</variation>
<location>
<position position="419"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="41"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="46"/>
<end position="48"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="51"/>
<end position="53"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="54"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="67"/>
<end position="73"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="76"/>
<end position="81"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="84"/>
<end position="91"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="92"/>
<end position="98"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="105"/>
<end position="111"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="116"/>
<end position="118"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="121"/>
<end position="137"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="138"/>
<end position="141"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="143"/>
<end position="161"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="162"/>
<end position="165"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="171"/>
<end position="187"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="196"/>
<end position="212"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="215"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="230"/>
<end position="232"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="233"/>
<end position="256"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="267"/>
<end position="277"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="278"/>
<end position="280"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="288"/>
<end position="319"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="321"/>
<end position="334"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="337"/>
<end position="339"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="343"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="350"/>
<end position="363"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="378"/>
<end position="380"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="383"/>
<end position="385"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="390"/>
<end position="393"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="395"/>
<end position="399"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="402"/>
<end position="404"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="413"/>
<end position="416"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="419"/>
<end position="421"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="442"/>
<end position="459"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="460"/>
<end position="466"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="468"/>
<end position="470"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="476"/>
<end position="483"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="489"/>
<end position="493"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2P85"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PG5"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4EJH"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P00176"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q64458"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11016631"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12130698"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12721789"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15063809"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15618722"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18779312"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000305"/>
<sequence length="494" mass="56688" checksum="A39F18AD71C28821" modified="2005-10-11" version="3">
MLASGLLLVTLLACLTVMVLMSVWRQRKSRGKLPPGPTPLPFIGNYLQLNTEQMYNSLMK
ISERYGPVFTIHLGPRRVVVLCGHDAVKEALVDQAEEFSGRGEQATFDWLFKGYGVAFSN
GERAKQLRRFSIATLRGFGVGKRGIEERIQEEAGFLIDALRGTHGANIDPTFFLSRTVSN
VISSIVFGDRFDYEDKEFLSLLRMMLGSFQFTATSTGQLYEMFSSVMKHLPGPQQQAFKE
LQGLEDFIAKKVEHNQRTLDPNSPRDFIDSFLIRMQEEEKNPNTEFYLKNLVMTTLNLFF
AGTETVSTTLRYGFLLLMKHPEVEAKVHEEIDRVIGKNRQPKFEDRAKMPYTEAVIHEIQ
RFGDMLPMGLAHRVNKDTKFRDFFLPKGTEVFPMLGSVLRDPRFFSNPRDFNPQHFLDKK
GQFKKSDAFVPFSIGKRYCFGEGLARMELFLFFTTIMQNFRFKSPQSPKDIDVSPKHVGF
ATIPRNYTMSFLPR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>